Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVID-19.Read More.
Experts from the Seattle Cancer Care Alliance (SCCA)—a Member Institution of the National Comprehensive Cancer Network (NCCN)—are sharing insights and advice on how to continue providing optimal cancer care during the novel coronavirus (COVID-19) pandemic.Read More.
Experts offer their shared and unique predictions on the next big thing(s) in telehealth in 2020.Read More.
A study has found there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen […]Read More.
SOURCE: https://www.who.int/ Speaker key: MH Dr Margaret Harris TAG Dr Tedros Adhanom Ghebreyesus KA Kai MK Dr Maria Van Kerkhove […]Read More.
A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types.Read More.
Researchers are exploring the use of experimental medication to prevent heart disease for chemo-resistant ovarian cancerRead More.
Geneva, Switzerland, 27 March 2020 – As the world faces its biggest pandemic within the century, now is the right […]Read More.
Blockchain in Healthcare Today (BHTY) asked the world’s blockchain in healthcare experts to share their insights. Here, our internationally-renowned BHTY peer-review board discusses their major predictions.Read More.